Followers | 24 |
Posts | 2408 |
Boards Moderated | 0 |
Alias Born | 04/12/2006 |
Monday, August 17, 2020 10:42:49 AM
My favorite quote “ Labs are going to be eliminated from the equation.” Bye bye Covid testing for Bioreference Lab. DeGen
Bull & Bear Trading
1) The Yale test is by no means "Free." The lab costs associated with the Yale test will NOT be only $10. Overnight shipping costs to the lab will alone cost $25, maybe $40. Those who know the diagnostics industry understand that you can't get in the door for less than $80, and probably more for Covid testing. So let's dismiss the notion that anything will be free, we should all know better than this.
2) Sorrento CEO Henry Ji has stated that the SRNE-Columbia test might cost only $10. The SRNE test is an on site test that does not require a lab. The SRNE test is much cheaper than the Yale test because there are no shipping and/or lab costs for the SRNE test, but these costs are required for Yale test. ADVANTAGE ON COST GOES TO SORRENTO.
3) The testing space is evolving rapidly. Saliva is the new medium for testing. However, sending anything off to a lab is becoming a deal-breaker because the time delay makes the test almost useless. Labs are going to be removed from the equation. On-site initial testing and confirmation is the new gold standard. SRNE meets this qualification. Yale does not. ADVANTAGE OF NO LAB TESTING REQUIRED GOES TO SORRENTO.
4) The term "rapid testing" is now also evolving. Rapid testing will very soon refer to receiving test results within minutes. Rapid testing will not mean hours, and certainly not days. SRNE's test is only 30-minutes. The Yale test has to be sent off to a lab. Even if the Yale test can be completed in hours, unless somebody has access to a lab, then they must deliver the test to a lab. This time delay is unacceptable. Even if somebody has access to a testing lab, the Yale test will take hours vs SRNE's 30-minute test. Columbia has indicated that the testing time could be as little as 15-minutes if very simple items like pre-heating the bath solution is completed ahead of time. ADVANTAGE OF RAPID TESTING SPEED GOES TO SORRENTO.
5) Sorrento's test is the highest level of both sensitivity and specificity measuring 97% and 100% respectively. Yale's testing capabilities may be much lower. It should be a concern that the Yale researchers have not been forthcoming with their numbers on specificity and sensitivity. Yale has been marketing their test as cheap. Americans want affordable, but highly accurate. The entire world demands that an important Covid test be affordable and highly accurate, not just cheap. In stark contrast, the SRNE-Columbia researchers have clearly stated that 97% sensitivity and 100% specificity are the capabilities of their rapid, saliva-based test. ADVANTAGE OF TESTING ACCURACY GOES TO SORRENTO.
Clearly, Sorrento's COVI-TRACE is going to be the gold standard for the literally billions of essential Covid tests that can take place. Only the Sorrento-Columbia COVI-TRACE checks all the boxes here for rapid testing, affordable testing, highly accurate testing, and saliva-based testing. Without any ambiguity, the Sorrento-Columbia COVI-TRACE product is acknowledged as the "BEST IN CLASS" Covid test.
The FDA is desperate for COVI-TRACE to be given an EUA so that the national nightmare of overwhelmed testing labs can be alleviated. We are days away from the start of flu season, the nation is struggling to reopen local economies, schools and colleges are wanting to reopen, and even sports leagues want to play ball. The nation is desperate for the gold standard in Covid testing, COVI-TRACE is that gold standard product.
Recent OPK News
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 08/23/2024 09:33:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 09:23:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:50:25 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 08/12/2024 10:27:05 PM
- Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 08/09/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 09:39:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 08:12:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 08:07:42 PM
- OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results • GlobeNewswire Inc. • 08/07/2024 08:06:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 08:21:51 PM
- OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024 • GlobeNewswire Inc. • 08/01/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/31/2024 09:03:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 11:49:22 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 07/26/2024 11:43:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 11:18:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 11:15:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 11:11:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 11:08:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 11:05:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/23/2024 09:16:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2024 10:46:15 PM
- OPKO Health Announces $100 Million Share Repurchase Program • GlobeNewswire Inc. • 07/18/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2024 08:23:35 PM
- OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA’s Profit Share Payments • GlobeNewswire Inc. • 07/17/2024 08:14:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/09/2024 08:07:09 PM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM